INLB (Item 9 Labs) E10: $-1.56 (As of Jun. 2023)


INLB Item 9 Labs Corp INLB
12 GF Score
Price $0.00
View Full Analysis

What is Item 9 Labs E10?

Item 9 Labs INLB -99.00% 12 E10 is $-1.56 as of Jun. 2023. GuruFocus rates INLB with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Item 9 Labs's adjusted earnings per share data for the three months ended in Jun. 2023 was $-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.56 for the trailing ten years ended in Jun. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Item 9 Labs's current stock price is $0.0001. Item 9 Labs's E10 for the quarter that ended in Jun. 2023 was $-1.56. Item 9 Labs's Shiller PE Ratio of today is .


Item 9 Labs  (OTCPK:INLB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Item 9 Labs E10 Related Terms


Item 9 Labs E10 Historical Data

* Premium members only.

The historical data trend for Item 9 Labs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Item 9 Labs E10 Chart

Item 9 Labs Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -2.11 -1.82 -1.61

Item 9 Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.60 -1.61 -1.58 -1.59 -1.56

INLB vs NEPT, CENBF, SGBI: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Item 9 Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Item 9 Labs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Item 9 Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Item 9 Labs's Shiller PE Ratio falls into.


INLB
12GF Score
Item 9 Labs Corp INLB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Item 9 Labs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Item 9 Labs's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.06/305.1090*305.1090
=-0.060

Current CPI (Jun. 2023) = 305.1090.

Item 9 Labs Quarterly Data

per share eps CPI Adj_EPS
201309 -1.000 234.149 -1.303
201312 -0.600 233.049 -0.786
201403 -7.200 236.293 -9.297
201406 -0.200 238.343 -0.256
201409 0.400 238.031 0.513
201412 -0.200 234.812 -0.260
201503 -0.400 236.119 -0.517
201506 -0.200 238.638 -0.256
201509 -0.600 237.945 -0.769
201512 -0.200 236.525 -0.258
201603 -0.400 238.132 -0.513
201606 -0.200 241.018 -0.253
201609 -0.200 241.428 -0.253
201612 -0.013 241.432 -0.016
201703 -0.012 243.801 -0.015
201706 -0.002 244.955 -0.002
201709 -0.010 246.819 -0.012
201712 -0.200 246.524 -0.248
201803 -0.002 249.554 -0.002
201806 -0.010 251.989 -0.012
201809 -0.006 252.439 -0.007
201812 -0.010 251.233 -0.012
201903 -0.010 254.202 -0.012
201906 -0.010 256.143 -0.012
201909 -0.130 256.759 -0.154
201912 -0.030 256.974 -0.036
202003 -0.030 258.115 -0.035
202006 -0.030 257.797 -0.036
202009 -0.120 260.280 -0.141
202012 -0.020 260.474 -0.023
202103 0.001 264.877 0.001
202106 -0.010 271.696 -0.011
202109 -0.110 274.310 -0.122
202112 -0.040 278.802 -0.044
202203 -0.040 287.504 -0.042
202206 -0.060 296.311 -0.062
202209 -0.200 296.808 -0.206
202212 -0.030 296.797 -0.031
202303 -0.030 301.836 -0.030
202306 -0.060 305.109 -0.060

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1.56 mean?
Item 9 Labs (INLB) has a E10 of $-1.56 as of Jun. 2023. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Item 9 Labs and its competitors.
Is Item 9 Labs' E10 too high?
Item 9 Labs' current E10 is $-1.56. Overall, Item 9 Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Item 9 Labs' E10 compare to NEPT and CENBF?
Item 9 Labs' E10 of $-1.56 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Item 9 Labs and its competitors. Item 9 Labs's current E10 is $-1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Item 9 Labs stock overvalued right now?
Item 9 Labs (INLB) has a current E10 of $-1.56. The current E10 is $-1.56. Item 9 Labs' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Item 9 Labs (INLB), the current E10 is $-1.56 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Item 9 Labs Business Description

Address 2111 E. Highland Avenue, Suite B375, Phoenix, AZ, USA, 85016
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
12GF Score

Get the complete analysis for INLB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price